Donald Danforth Plant Science Center, St. Louis, MO, USA.
BMC Plant Biol. 2018 Jun 25;18(1):132. doi: 10.1186/s12870-018-1354-x.
Morphogenic culture systems are central to crop improvement programs that utilize transgenic and genome editing technologies. We previously reported that CMD2-type cassava (Manihot esculenta) cultivars lose resistance to cassava mosaic disease (CMD) when passed through somatic embryogenesis. As a result, these plants cannot be developed as products for deployment where CMD is endemic such as sub-Saharan Africa or the Indian sub-continent.
In order to increase understanding of this phenomenon, 21 African cassava cultivars were screened for resistance to CMD after regeneration through somatic embryogenesis. Fifteen cultivars were shown to retain resistance to CMD through somatic embryogenesis, confirming that the existing transformation and gene editing systems can be employed in these genetic backgrounds without compromising resistance to geminivirus infection. CMD2-type cultivars were also subjected to plant regeneration via caulogenesis and meristem tip culture, resulting in 25-36% and 5-10% of regenerated plant lines losing resistance to CMD respectively.
This study provides clear evidence that multiple morphogenic systems can result in loss of resistance to CMD, and that somatic embryogenesis per se is not the underlying cause of this phenomenon. The information described here is critical for interpreting genomic, transcriptomic and epigenomic datasets aimed at understanding CMD resistance mechanisms in cassava.
形态发生培养系统是利用转基因和基因组编辑技术进行作物改良计划的核心。我们之前曾报道过,通过体细胞胚胎发生途径,CMD2 型木薯(Manihot esculenta)品种会失去对木薯花叶病(CMD)的抗性。因此,这些植物不能作为在 CMD 流行地区(如撒哈拉以南非洲或印度次大陆)部署的产品开发。
为了增加对这一现象的理解,我们对 21 种非洲木薯品种进行了筛选,以评估它们在经过体细胞胚胎发生再生后的 CMD 抗性。结果显示,有 15 个品种在体细胞胚胎发生过程中保持了对 CMD 的抗性,这证实了现有的转化和基因编辑系统可以在这些遗传背景下使用,而不会影响对双生病毒感染的抗性。我们还通过茎生芽发生和茎尖培养对 CMD2 型品种进行了植物再生,分别有 25-36%和 5-10%的再生植株系失去了对 CMD 的抗性。
本研究提供了明确的证据,证明多种形态发生系统可能导致对 CMD 的抗性丧失,而且体细胞胚胎发生本身并不是导致这种现象的根本原因。这里描述的信息对于解释旨在了解木薯 CMD 抗性机制的基因组、转录组和表观基因组数据集至关重要。